Jennison Associates Portfolio holdings
Jennison Associates, founded in 1969 and headquartered in New York City, is a global investment management firm managing over $194 billion in assets as of late 2024, specializing in active equity and fixed-income strategies. A subsidiary of PGIM, the asset management arm of Prudential Financial, Jennison serves a diverse client base—including institutions, sub-advisory clients, public plans, endowments, and corporations—with a focus on fundamental research, bottom-up portfolio construction, and high-conviction investing. Known for its equity expertise across styles, geographies, and market capitalizations, as well as investment-grade fixed-income offerings, the firm employs seasoned portfolio managers averaging 29 years of industry experience and 16 years with Jennison. With additional offices in Boston and a culture emphasizing intellectual rigor and long-term client outcomes, Jennison has built a reputation for excellence and stability in the investment management industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Advanced Micro Devices
AMD
|
+$1.32B |
| 2 |
AstraZeneca
AZN
|
+$733M |
| 3 |
Microsoft
MSFT
|
+$728M |
| 4 |
Cadence Design Systems
CDNS
|
+$720M |
| 5 |
Moody's
MCO
|
+$359M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alcon
ALC
|
+$1.43B |
| 2 |
Estee Lauder
EL
|
+$872M |
| 3 |
Eli Lilly
LLY
|
+$626M |
| 4 |
Netflix
NFLX
|
+$521M |
| 5 |
UnitedHealth
UNH
|
+$466M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 33.19% |
| 2 | Consumer Discretionary | 19.62% |
| 3 | Healthcare | 16.16% |
| 4 | Financials | 9.12% |
| 5 | Communication Services | 8.08% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
PDCE
76
DELISTED
PDC Energy, Inc.
PDCE
| $169M | 0.16% |
2,632,430
+138,819
| +6% | +$8.98M |
|
|
XIFR
77
XPLR Infrastructure LP
XIFR
$1.11B
| $168M | 0.15% |
2,759,605
+11,346
| +0.4% | +$780K |
|
78
Cheniere Energy
LNG
$53.9B
| $158M | 0.15% |
1,003,221
-969,151
| -49% | -$146M |
|
79
On Holding
ONON
$12.5B
| $158M | 0.15% |
5,095,045
+2,223,076
| +77% | +$50.3M |
|
80
Walmart Inc
WMT
$888B
| $155M | 0.14% |
3,161,187
-472,860
| -13% | -$22.4M |
|
81
Procter & Gamble
PG
$345B
| $151M | 0.14% |
1,015,170
-172,737
| -15% | -$24.7M |
|
82
RTX Corp
RTX
$294B
| $146M | 0.13% |
1,493,972
-20,455
| -1% | -$2.01M |
|
83
CMS Energy
CMS
$22.5B
| $145M | 0.13% |
2,362,729
-112,805
| -5% | -$6.93M |
|
84
Shift4
FOUR
$4.41B
| $144M | 0.13% |
1,897,897
-364,182
| -16% | -$23.5M |
|
85
Southern Company
SO
$107B
| $144M | 0.13% |
2,064,731
+743,333
| +56% | +$50.1M |
|
86
Ameren
AEE
$30.3B
| $137M | 0.13% |
1,587,296
-1,587,286
| -50% | -$136M |
|
87
PepsiCo
PEP
$190B
| $137M | 0.13% |
751,555
-238,945
| -24% | -$41.8M |
|
88
Sempra
SRE
$56.6B
| $136M | 0.12% |
1,796,314
-317,182
| -15% | -$24.3M |
|
89
Lam Research
LRCX
$398B
| $135M | 0.12% |
2,549,770
+227,520
| +10% | +$11.2M |
|
90
DTE Energy
DTE
$29.5B
| $134M | 0.12% |
1,227,807
+78,905
| +7% | +$8.84M |
|
91
MetLife
MET
$61.9B
| $133M | 0.12% |
2,297,638
-50,162
| -2% | -$3.39M |
|
92
Chord Energy
CHRD
$7.71B
| $128M | 0.12% |
948,338
+9,604
| +1% | +$1.3M |
|
93
Johnson Controls International
JCI
$93.1B
| $127M | 0.12% |
2,111,273
-55,031
| -3% | -$3.52M |
|
94
Merck
MRK
$316B
| $126M | 0.12% |
1,187,948
-193,606
| -14% | -$20.9M |
|
95
PNC Financial Services
PNC
$101B
| $125M | 0.11% |
981,342
-79,848
| -8% | -$12M |
|
|
HES
96
DELISTED
Hess
HES
| $124M | 0.11% |
940,233
-160,088
| -15% | -$22.3M |
|
97
Chevron
CVX
$379B
| $122M | 0.11% |
746,449
-198,343
| -21% | -$33.3M |
|
98
Constellation Energy
CEG
$95.4B
| $116M | 0.11% |
1,475,903
-829,980
| -36% | -$67.1M |
|
99
Stryker
SYK
$129B
| $111M | 0.1% |
390,415
-12,639
| -3% | -$3.35M |
|
100
Cisco
CSCO
$480B
| $109M | 0.1% |
2,094,026
-35,934
| -2% | -$1.75M |
|
Similar funds
Jennison Associates's Q1 2023 Portfolio in Review
As of Q1 2023, Jennison Associates held 644 positions worth $109B, up 10% from $98.7B the previous quarter. Its ten largest holdings account for 39% of the portfolio.
Jennison Associates withdrew a net $3.94B in Q1 2023, closing 63 positions and reducing 280 holdings. Its most notable exit was Alcon, an estimated $1.43B position sold in full.
By sector, the portfolio is most concentrated in Technology at 33% of assets, up from 26% a quarter earlier, followed by Consumer Discretionary and Healthcare.
Against the trend, Jennison Associates opened a new position in Advanced Micro Devices worth $1.59B.
- Jennison Associates's largest Q1 2023 buy was Advanced Micro Devices: 16,272,765 shares worth $1.59B.
- Jennison Associates added most to AstraZeneca in Q1 2023, an estimated $733M increase.
- Jennison Associates's biggest Q1 2023 reduction was Estee Lauder, cutting an estimated $872M.
- Jennison Associates fully exited Alcon in Q1 2023, selling an estimated $1.43B.
- Jennison Associates's ten largest holdings make up 39% of its $109B portfolio in Q1 2023.
- Jennison Associates opened 73 new positions and closed 63 in Q1 2023.
- Jennison Associates's portfolio value rose 10% quarter-over-quarter to $109B.
Based on Jennison Associates's 13F filing for Q1 2023, filed 26 Apr 2023.